Luye Pharma Says Five New Products Added to China's Drug Reimbursement List

MT Newswires Live

2025/12/08

Luye Pharma Group (HKG:2186) said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.

Shares of the company gained over 1% in morning trade Monday.

Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.

Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2589388084"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2589388084\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2589388084?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-08 11:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589388084","market":"sh","top_or_hot":-1,"title":"Luye Pharma Says Five New Products Added to China's Drug Reimbursement List","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/LYPHF\">Luye Pharma</a> Group (HKG:2186) said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.</p><p>Shares of the company gained over 1% in morning trade Monday.</p><p>Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.</p><p>Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Luye Pharma Says Five New Products Added to China's Drug Reimbursement List</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLuye Pharma Says Five New Products Added to China's Drug Reimbursement List\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-12-08 11:08</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/LYPHF\">Luye Pharma</a> Group (HKG:2186) said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.</p><p>Shares of the company gained over 1% in morning trade Monday.</p><p>Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.</p><p>Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2589388084","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589388084","pubTimestamp":1765163295,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Luye Pharma Group  said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.Shares of the company gained over 1% in morning trade Monday.Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","BK1606":"中医药概念","02186":"绿叶制药","BK1191":"制药"},"translate_title":"绿叶制药称中国药品报销目录新增5个产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02186":1},"content_text":"Luye Pharma Group (HKG:2186) said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.Shares of the company gained over 1% in morning trade Monday.Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}